Global Cell Banking Market Trends, Opportunities, and Future

Global Cell Banking Market Trends, Opportunities, and Future

As Outsourcing of Cell Line Development Services Drives the Market, Contract Service Providers Focus on Providing End-to-end Services by Expanding the

RELEASE DATE
11-Jan-2017
REGION
North America
Research Code: 9AB9-00-63-00-00
SKU: HC02713-NA-MR_19333
AvailableYesPDF Download
$1,500.00
In stock
SKU
HC02713-NA-MR_19333
$1,500.00
DownloadLink
ENQUIRE NOW

Description

This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020.

The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by specialized and technologically advanced services offered by CROs/CMOs, growing demand for gene and cell therapy, and increased partnerships with biopharmaceutical companies. Also, there are an increasing number of grants, incentives, and private investments in research on cell therapeutics and biopharmaceuticals. Master cell banking and storage accounted for the largest shares of cell banking revenue, among the different bank types, and the different phases of cell banking, respectively, in 2015.

The study also provides market forecasts for cell line development, a preliminary step to cell banking. Cell line development is driven by technological advancements and increasing demand for cancer therapeutics and monoclonal antibodies. Mammalian cell lines are the most used source for cell line development in all regions. The United States leads in cell line development and cell banking, closely followed by Europe and Asia-Pacific. The fastest growth rate was experienced in Asia-Pacific, with the hotbeds in India and China. Due to increasing demand for cell lines and cell banking, CMOs/CROs are focusing on providing end-to-end services by expanding their service portfolio and collaborating with biopharmaceutical companies.

Table of Contents

Key Findings

Scope and Segmentation

Market Overview

Market Revenue Forecasts Snapshot

Market Trends

Industry Value Chain

8 Big Market Themes for Cell Banking

Global Market Perspective

In-house and Outsourced Cell Banking—Large Pharma

In-house and Outsourced Cell Banking—Generic Pharma

In-house and Outsourced Cell Banking—Biotech

In-house and Outsourced Cell Banking

Out-sourced Cell Banking Trends

Regional Trends in the Cell Banking Market

Market Drivers

Drivers Explained

Drivers Explained (continued)

Market Restraints

Restraints Explained

Restraints Explained (continued)

Market Revenue Forecasts Approach

Cell Line Development Market—Revenue Forecast

Revenue Forecast Discussion

Cell Banking Market—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Revenue Forecast Discussion (continued)

Biologics Safety Testing Market—Revenue Forecast

Revenue Forecast Discussion

Revenue Forecast Discussion (continued)

Transformation in Pharmaceutical Industry Eco-system

4 Major Growth Opportunities

Strategic Imperatives for CMOs and CROs

Legal Disclaimer

The Frost & Sullivan Story

Value Proposition: Future of Your Company & Career

Global Perspective

Industry Convergence

360º Research Perspective

Implementation Excellence

Our Blue Ocean Strategy

Related Research
This research service on the global cell banking market addresses market sizing, emerging trends, and technologies and provides a snapshot of the key participants in the market. The base year considered is 2015 and forecasts are provided from 2016 to 2020. The cell banking market is expected to grow at a CAGR of 16.7% till 2020, driven by specialized and technologically advanced services offered by CROs/CMOs, growing demand for gene and cell therapy, and increased partnerships with biopharmaceutical companies. Also, there are an increasing number of grants, incentives, and private investments in research on cell therapeutics and biopharmaceuticals. Master cell banking and storage accounted for the largest shares of cell banking revenue, among the different bank types, and the different phases of cell banking, respectively, in 2015. The study also provides market forecasts for cell line development, a preliminary step to cell banking. Cell line development is driven by technological advancements and increasing demand for cancer therapeutics and monoclonal antibodies. Mammalian cell lines are the most used source for cell line development in all regions. The United States leads in cell line development and cell banking, closely followed by Europe and Asia-Pacific. The fastest growth rate was experienced in Asia-Pacific, with the hotbeds in India and China. Due to increasing demand for cell lines and cell banking, CMOs/CROs are focusing on providing end-to-end services by expanding their service portfolio and collaborating with biopharmaceutical companies.
More Information
No Index No
Podcast No
Author Shweta Pankaj
Industries Healthcare
WIP Number 9AB9-00-63-00-00
Is Prebook No